Kensuke Ueno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kensuke Ueno has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Junya Ako
Department of Cardiovascular Medicine, Kitasato University School of Medicine , Sagamihara
5 shared publications - Kentaro Kamiya
Department of Rehabilitation Sciences Kitasato University Graduate School of Medical Sciences Sagamihara Japan
5 shared publications - Atsuhiko Matsunaga
Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences , Sagamihara
4 shared publications - Minako Yamaoka-Tojo
Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences , Sagamihara
4 shared publications - Takumi Noda
Department of Cardiovascular Rehabilitation, National Cerebral and Cardiovascular Center , Suita
4 shared publications - Emi Maekawa
Department of Cardiovascular Medicine, Kitasato University School of Medicine , Sagamihara
3 shared publications
Latest Publications
- 19 June 2026
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
Cardiac Rehabilitation and Long-Term Prognosis in Cardiovascular Disease Patients with Cancer History
Background: Cancer and cardiovascular disease (CVD) share common risk factors, and the development of CVD in cancer survivors is a significant event that worsens prognosis. Comprehensive cardiac rehabilitation (CR) has been reported to be associated with improved prognosis, including risk of death and rehospitalisation, in patients with CVD. However, the benefits of CR to patients with both cancer and CVD is unclear. Aims: This study aimed to investigate the usefulness of CR in CVD patients with cancer history. Methods: We retrospectively reviewed 1,424 CVD patients with a cancer history (median age: 76 [69–81] years). Primary and secondary outcomes were all-cause mortality and composite events of all-cause death and CVD-related rehospitalisation, respectively. CR participation was defined as attending rehabilitation at least once within three months of discharge. We performed propensity score (PS) matching for CR, followed by Cox regression analysis, to assess the association between CR and prognosis. Results: During the median follow-up period of 1.8 (0.7–3.4) years, 286 deaths and 465 composite events occurred. After PS matching, 1,008 patients (504 pairs) were included, with standardised mean differences of < 0.1 for all covariates. CR participation was associated with a significantly lower risk of all-cause mortality (Hazard ratio [HR]: 0.54, 95% confidence interval [CI]: 0.41–0.73, P < 0.001) and composite event rates (HR: 0.62, 95% CI: 0.50–0.78, P < 0.001) compared to CR non-participation. Conclusion: CR participation was associated with a lower risk of poor prognostic events in CVD patients with a history of cancer.
- 19 June 2026
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
Cardiac Rehabilitation and Long-Term Prognosis in Cardiovascular Disease Patients with Cancer History
Background: Cancer and cardiovascular disease (CVD) share common risk factors, and the development of CVD in cancer survivors is a significant event that worsens prognosis. Comprehensive cardiac rehabilitation (CR) has been reported to be associated with improved prognosis, including risk of death and rehospitalisation, in patients with CVD. However, the benefits of CR to patients with both cancer and CVD is unclear. Aims: This study aimed to investigate the usefulness of CR in CVD patients with cancer history. Methods: We retrospectively reviewed 1,424 CVD patients with a cancer history (median age: 76 [69–81] years). Primary and secondary outcomes were all-cause mortality and composite events of all-cause death and CVD-related rehospitalisation, respectively. CR participation was defined as attending rehabilitation at least once within three months of discharge. We performed propensity score (PS) matching for CR, followed by Cox regression analysis, to assess the association between CR and prognosis. Results: During the median follow-up period of 1.8 (0.7–3.4) years, 286 deaths and 465 composite events occurred. After PS matching, 1,008 patients (504 pairs) were included, with standardised mean differences of < 0.1 for all covariates. CR participation was associated with a significantly lower risk of all-cause mortality (Hazard ratio [HR]: 0.54, 95% confidence interval [CI]: 0.41–0.73, P < 0.001) and composite event rates (HR: 0.62, 95% CI: 0.50–0.78, P < 0.001) compared to CR non-participation. Conclusion: CR participation was associated with a lower risk of poor prognostic events in CVD patients with a history of cancer.
- 14 May 2026
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
- Vol. 25 (6) , 1243-1251
Ability of the FRAIL scale questionnaire to screen physical frailty and its prognostic value in older patients with cardiovascular disease and cognitive decline
Aims: The FRAIL scale questionnaire is a brief measure of physical frailty in patients with cardiovascular disease (CVD); however, its performance in those with concomitant cognitive impairment remains uncertain. We investigated the accuracy of the FRAIL scale in identifying physical frailty defined by the Fried criteria and its association with adverse events in older patients with CVD and cognitive decline. Methods and results: This retrospective cohort study comprised 318 patients (male, 66.7%; median age, 79 years) with CVD (≥60 years old) who had cognitive impairment (Mini-Cog <3 points) and completed the FRAIL scale. The accuracy of the FRAIL scale for identifying physical frailty was evaluated using the area under the curve (AUC). Associations with frailty, motor functions (e.g. leg strength, walking speed, 6-min walk test distance), and prognosis was tested using multivariable regression models and survival analysis. The AUC for predicting physical frailty was 0.749 (95% confidence interval [CI], 0.697–0.801). Higher FRAIL scale scores were associated with physical frailty (adjusted odds ratio, 2.087; 95% CI, 1.647–2.645) and motor function decline (all P < 0.05). During follow-up (median, 335 days), 70 patients experienced the first composite event (all-cause death or cardiovascular rehospitalization). Frailty assessed by the FRAIL scale was associated with higher composite event rates (adjusted hazard ratio, 1.918; 95% CI, 1.134–3.243). Conclusion: In older patients with CVD and cognitive decline, higher FRAIL scale scores are associated with objectively assessed physical frailty and worse prognosis. These findings indicate that the FRAIL scale questionnaire is applicable for frailty screening and risk stratification in this population.
- 14 May 2026
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
- Vol. 25 (6) , 1243-1251
Ability of the FRAIL scale questionnaire to screen physical frailty and its prognostic value in older patients with cardiovascular disease and cognitive decline
Aims: The FRAIL scale questionnaire is a brief measure of physical frailty in patients with cardiovascular disease (CVD); however, its performance in those with concomitant cognitive impairment remains uncertain. We investigated the accuracy of the FRAIL scale in identifying physical frailty defined by the Fried criteria and its association with adverse events in older patients with CVD and cognitive decline. Methods and results: This retrospective cohort study comprised 318 patients (male, 66.7%; median age, 79 years) with CVD (≥60 years old) who had cognitive impairment (Mini-Cog <3 points) and completed the FRAIL scale. The accuracy of the FRAIL scale for identifying physical frailty was evaluated using the area under the curve (AUC). Associations with frailty, motor functions (e.g. leg strength, walking speed, 6-min walk test distance), and prognosis was tested using multivariable regression models and survival analysis. The AUC for predicting physical frailty was 0.749 (95% confidence interval [CI], 0.697–0.801). Higher FRAIL scale scores were associated with physical frailty (adjusted odds ratio, 2.087; 95% CI, 1.647–2.645) and motor function decline (all P < 0.05). During follow-up (median, 335 days), 70 patients experienced the first composite event (all-cause death or cardiovascular rehospitalization). Frailty assessed by the FRAIL scale was associated with higher composite event rates (adjusted hazard ratio, 1.918; 95% CI, 1.134–3.243). Conclusion: In older patients with CVD and cognitive decline, higher FRAIL scale scores are associated with objectively assessed physical frailty and worse prognosis. These findings indicate that the FRAIL scale questionnaire is applicable for frailty screening and risk stratification in this population.
- Open Access
- 14 March 2026
- Published by Elsevier in SSRN Electronic Journal
Respiratory muscle strength and exercise tolerance in older patients with heart failure and preserved or reduced lower-extremity function
Introduction: Aside from lower-extremity function, respiratory muscle function may be an additional indicator of exercise tolerance in older patients with heart failure (HF). We aimed to clarify the association between respiratory muscle strength and exercise tolerance in older patients with HF and the presence or absence of lower-extremity function decline.Methods: We studied 552 patients aged ≥65 years admitted due to HF medical treatment. Short Physical Performance Battery (SPPB) ≤9 and 6-min walking distance (6MWD) <300 m were defined as lower-extremity function decline and exercise intolerance, respectively. Maximal inspiratory pressure (PImax) was measured as respiratory muscle strength. We analysed the association of PImax with 6MWD in subgroups of SPPB ≤9 points and the additive effect of PImax on SPPB for predicting 6MWD <300 m.Results: After adjusting for clinical characteristics, PImax was independently associated with 6MWD (partial regression coefficient per PImax of 5 cmH2O: 5.62, 95% confidence interval [CI]: 4.14–7.11, P <0.001). This association was consistently observed in patients with the presence or absence of SPPB ≤9. While the area under the receiver operating characteristic curve of SPPB alone for 6MWD <300 m was 0.886 (95% CI: 0.858–0.915), the curve of SPPB plus PImax was 0.909 (95% CI: 0.884–0.933), with a significant improvement in predicting 6MWD <300 m (P = 0.005).Conclusions: Respiratory muscle strength in older patients with HF is a relevant marker of exercise tolerance, regardless of lower-extremity function decline, and has an additive effect on lower-extremity function in identifying exercise intolerance.
- 14 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessRespiratory muscle strength and exercise tolerance in older patients with heart failure and preserved or reduced lower-extremity function
Introduction: Aside from lower-extremity function, respiratory muscle function may be an additional indicator of exercise tolerance in older patients with heart failure (HF). We aimed to clarify the association between respiratory muscle strength and exercise tolerance in older patients with HF and the presence or absence of lower-extremity function decline.Methods: We studied 552 patients aged ≥65 years admitted due to HF medical treatment. Short Physical Performance Battery (SPPB) ≤9 and 6-min walking distance (6MWD) <300 m were defined as lower-extremity function decline and exercise intolerance, respectively. Maximal inspiratory pressure (PImax) was measured as respiratory muscle strength. We analysed the association of PImax with 6MWD in subgroups of SPPB ≤9 points and the additive effect of PImax on SPPB for predicting 6MWD <300 m.Results: After adjusting for clinical characteristics, PImax was independently associated with 6MWD (partial regression coefficient per PImax of 5 cmH2O: 5.62, 95% confidence interval [CI]: 4.14–7.11, P <0.001). This association was consistently observed in patients with the presence or absence of SPPB ≤9. While the area under the receiver operating characteristic curve of SPPB alone for 6MWD <300 m was 0.886 (95% CI: 0.858–0.915), the curve of SPPB plus PImax was 0.909 (95% CI: 0.884–0.933), with a significant improvement in predicting 6MWD <300 m (P = 0.005).Conclusions: Respiratory muscle strength in older patients with HF is a relevant marker of exercise tolerance, regardless of lower-extremity function decline, and has an additive effect on lower-extremity function in identifying exercise intolerance.
- 5 February 2024
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
- Vol. 23 (6) , 675-684
Screening for sarcopenia with SARC-F in older patients hospitalized with cardiovascular disease
Aims: SARC-F ≥ 4 points are used for detecting sarcopenia; however, finding a lower SARC-F cut-off value may lead to early detection of sarcopenia. We investigated the SARC-F score with the highest sensitivity and specificity values to identify sarcopenia in older patients with cardiovascular disease (CVD). Motor performances were also examined for each SARC-F score. Methods and results: This retrospective cross-sectional study examined the sensitivity and specificity of every 1-point increase in the SARC-F score to predict sarcopenia. Eligible participants included patients with CVD (≥65 years old) who were admitted for acute CVD treatment and participated in cardiac rehabilitation. Patients completed the SARC-F questionnaire and the sarcopenia assessment. Area under the curves (AUCs) were investigated for the ability to predict sarcopenia. Multivariable linear regression was used to compare the mean value of physical functions (e.g. walking speed, leg strength, and 6 min walking distance) of each SARC-F score. A total of 1066 participants (63.8% male; median age: 76 years) were included. Sarcopenia was present in 401 patients. A SARC-F cut-off ≥2 presented the optimal balance between sensitivity (68.3%) and specificity (55.6%) to detect sarcopenia (AUCs = 0.658; 95% confidence interval: 0.625–0.691). When the patients had low scores (1–3), every 1 point increase in the SARC-F score was associated with lower physical functions such as lower muscle strength and shorter walking distance (all P < 0.001). Conclusion: A SARC-F cut-off ≥2 was optimal for screening sarcopenia, and even a low SARC-F score is useful in detecting sarcopenia and low physical function at an early stage in patients with CVD.
- 5 February 2024
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
- Vol. 23 (6) , 675-684
Screening for sarcopenia with SARC-F in older patients hospitalized with cardiovascular disease
Aims: SARC-F ≥ 4 points are used for detecting sarcopenia; however, finding a lower SARC-F cut-off value may lead to early detection of sarcopenia. We investigated the SARC-F score with the highest sensitivity and specificity values to identify sarcopenia in older patients with cardiovascular disease (CVD). Motor performances were also examined for each SARC-F score. Methods and results: This retrospective cross-sectional study examined the sensitivity and specificity of every 1-point increase in the SARC-F score to predict sarcopenia. Eligible participants included patients with CVD (≥65 years old) who were admitted for acute CVD treatment and participated in cardiac rehabilitation. Patients completed the SARC-F questionnaire and the sarcopenia assessment. Area under the curves (AUCs) were investigated for the ability to predict sarcopenia. Multivariable linear regression was used to compare the mean value of physical functions (e.g. walking speed, leg strength, and 6 min walking distance) of each SARC-F score. A total of 1066 participants (63.8% male; median age: 76 years) were included. Sarcopenia was present in 401 patients. A SARC-F cut-off ≥2 presented the optimal balance between sensitivity (68.3%) and specificity (55.6%) to detect sarcopenia (AUCs = 0.658; 95% confidence interval: 0.625–0.691). When the patients had low scores (1–3), every 1 point increase in the SARC-F score was associated with lower physical functions such as lower muscle strength and shorter walking distance (all P < 0.001). Conclusion: A SARC-F cut-off ≥2 was optimal for screening sarcopenia, and even a low SARC-F score is useful in detecting sarcopenia and low physical function at an early stage in patients with CVD.
- Open Access
- 16 June 2023
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 2
Validity of Self-reported Self-Care Assessment and Determinants of Self-Care Practices in Older Patients with Heart Failure
Background: Self-care as a disease management strategy in heart failure (HF) is important for the prevention of rehospitalisation, but it is difficult to assess and does not always reflect actual self-care practices. This study aimed to compare self-reported self-care assessments and actual self-care practices in older patients with HF and examine factors influencing self-care performance. Methods: We included 64 patients with HF aged ≥65 years who had been hospitalised and prescribed rehabilitation with stable symptoms between April 2019 and September 2020. We assessed the B-type natriuretic peptide levels and New York Heart Association (NYHA) classification, Short Physical Performance Battery (SPPB), grip strength, and the Japanese version of the Montreal Cognitive Assessment (MoCA-J). We used the European Heart Failure Self-care Behaviour Scale (EHFScBS) to assess self-care behaviour in patients with HF. The patients filled in a self-assessment chart during their stay, which was used to work out the self-care implementation rate. Results: No significant correlation between the self-care implementation rate and the EHFScBS was identified (r= −0.160, p=0.207). Multiple regression analysis of factors associated with the rate of self-care and EHFScBS revealed that age, NYHA classification, SPPB and MoCA-J scores were significantly associated with the rate of self-care; however, no factors were associated with EHFScBS. The results were similar irrespective of the presence or absence of cognitive decline. Conclusion: In older patients with HF, the self-reported assessment of self-care did not reflect actual self-care performance. A reliable self-care behaviour scale needs to be developed.
- 16 June 2023
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 2
Open AccessValidity of Self-reported Self-Care Assessment and Determinants of Self-Care Practices in Older Patients with Heart Failure
Background: Self-care as a disease management strategy in heart failure (HF) is important for the prevention of rehospitalisation, but it is difficult to assess and does not always reflect actual self-care practices. This study aimed to compare self-reported self-care assessments and actual self-care practices in older patients with HF and examine factors influencing self-care performance. Methods: We included 64 patients with HF aged ≥65 years who had been hospitalised and prescribed rehabilitation with stable symptoms between April 2019 and September 2020. We assessed the B-type natriuretic peptide levels and New York Heart Association (NYHA) classification, Short Physical Performance Battery (SPPB), grip strength, and the Japanese version of the Montreal Cognitive Assessment (MoCA-J). We used the European Heart Failure Self-care Behaviour Scale (EHFScBS) to assess self-care behaviour in patients with HF. The patients filled in a self-assessment chart during their stay, which was used to work out the self-care implementation rate. Results: No significant correlation between the self-care implementation rate and the EHFScBS was identified (r= −0.160, p=0.207). Multiple regression analysis of factors associated with the rate of self-care and EHFScBS revealed that age, NYHA classification, SPPB and MoCA-J scores were significantly associated with the rate of self-care; however, no factors were associated with EHFScBS. The results were similar irrespective of the presence or absence of cognitive decline. Conclusion: In older patients with HF, the self-reported assessment of self-care did not reflect actual self-care performance. A reliable self-care behaviour scale needs to be developed.
- 8 February 2023
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 65 (1) , 45-51
Gait Speed and Cardiovascular Disease by Glycemic Status
- 8 February 2023
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 65 (1) , 45-51
Gait Speed and Cardiovascular Disease by Glycemic Status
- Open Access
- 25 July 2022
- Published by XMLink in Korean Circulation Journal
- Vol. 52 (8) , 576-592
Effectiveness and Approach of Rehabilitation in Patients With Acute Heart Failure: A Review
Korean Circulation Journal 대한심장학회지 순환기 Ueno K, et al. Korean Circ J. 2022 Jul;52:e77. https://doi.org/10.4070/kcj.2022.0181
- 25 July 2022
- Published by XMLink in Korean Circulation Journal
- Vol. 52 (8) , 576-592
Open AccessEffectiveness and Approach of Rehabilitation in Patients With Acute Heart Failure: A Review
Korean Circulation Journal 대한심장학회지 순환기 Ueno K, et al. Korean Circ J. 2022 Jul;52:e77. https://doi.org/10.4070/kcj.2022.0181